High Flow Nasal Cannula Market Size, Growth, Demands Outlook and Forecasts to 2030

According to the research report, the global high flow nasal cannula market size is expected to touch USD 15,926.4 million by 2030, from USD 5,431.5 million in 2020, growing with a significant CAGR of 11.3% from 2021 to 2030.

High Flow Nasal Cannula Market Size 2017-2030

The high flow nasal cannula market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global high flow nasal cannula market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global high flow nasal cannula market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global high flow nasal cannula market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1254

Market Scope

Report Highlights	Details
Market Size	USD 15,926.4 Billion by 2030
Growth Rate	CAGR of 11.3% from 2021 to 2030
Base Year	2020
Forecast Period	2021 to 2030
Historic Data	2017 to 2020
Segments Covered	Product, Application, End-User, Sales Channel, Region

This study covers a detailed segmentation of the global high flow nasal cannula market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global high flow nasal cannula market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

Armstrong Medical Ltd
Salter Labs Inc
ResMed, Inc.
Teleflex Inc
Vapotherm Inc.
Becton Dickinson, and Company
Smiths Medical
Flexicare Medical Ltd
Teijin Pharma Limited
TNI Medical AG
Fisher & Paykel Healthcare Limited
Hamilton Medical AG

Market Segmentation

By Product Type

Single heated tube
Nasal cannula
Active humidifier
Air blender

By Application

Acute Respiratory Failure
Chronic Obstructive Pulmonary Disease
Acute Heart Failure
Others

By End-user

Hospitals and clinics
Ambulatory care centers
Long-term care centers
Others

By Sales Channel

Direct Channel
Distribution Channel

By Geography

North America

U.S.
Canada

Europe

Germany
France
United Kingdom
Rest of Europe

Asia Pacific

China
Japan
India
Southeast Asia
Rest of Asia Pacific

Latin America

Brazil
Rest of Latin America

Middle East & Africa (MEA)

GCC
North Africa
South Africa
Rest of Middle East & Africa

Research Methodology

The research methodology adopted by analysts for compiling the global high flow nasal cannula market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global high flow nasal cannula market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Product Types
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. High Flow Nasal Cannula Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on High Flow Nasal Cannula Market

5.1. Covid-19: High Flow Nasal Cannula Industry Impact
5.2. High Flow Nasal Cannula Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and High Flow Nasal Cannula Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for High Flow Nasal Cannula Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. High Flow Nasal Cannula Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Ever-increasing number of respiratory disorders
6.1.1.2. Low cost of high-flow nasal cannula compared to low-flow oxygen delivery systems
6.1.2. Market Restraints
6.1.2.1. Low rate of adoption of modern healthcare applications in developing countries
6.1.3. Market Opportunities
6.1.3.1. Increasing popularity and uptake of heated humidified high-flow nasal cannulas

Chapter 7. Global High Flow Nasal Cannula Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. High Flow Nasal Cannula Market Revenue by Market Players (2017 - 2020)
7.1.1.2. High Flow Nasal Cannula Market Revenue Market Share by Market Players (2017 - 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio, Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End user

Chapter 8. Global High Flow Nasal Cannula Market, By Product Type

8.1. High Flow Nasal Cannula Market, by Product Type, 2017-2030
8.1.1. Single Heated Tube
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Nasal cannula
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Active humidifier
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Air blender
8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global High Flow Nasal Cannula Market, By End-user

9.1. High Flow Nasal Cannula Market, by End-user, 2017-2030
9.1.1. Hospitals and clinics
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Ambulatory care centers
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Long-term care centers
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global High Flow Nasal Cannula Market, By Application

10.1. High Flow Nasal Cannula Market, by Application, 2017-2030
10.1.1. Acute Respiratory Disorder
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Chronic Respiratory Disorder
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Acute Heart Failures
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global High Flow Nasal Cannula Market, By Sales Channel

11.1. High Flow Nasal Cannula Market, by Sales Channel, 2017-2030
11.1.1. Direct Channel
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Distribution Channel
11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global High Flow Nasal Cannula Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue Forecast by Product Type(2017-2030)
12.1.2. Market Revenue Forecast by End-user (2017-2030)
12.1.3. Market Revenue Forecast by Application (2017-2030)
12.1.4. Market Revenue Forecast by Sales Channel (2017-2030)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2017-2030)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2017-2030)
12.2. Europe
12.2.1. Market Revenue Forecast by Product Type (2017-2030)
12.2.2. Market Revenue Forecast by End-user (2017-2030)
12.2.3. Market Revenue Forecast by Application (2017-2030)
12.2.4. Market Revenue Forecast by Sales Channel (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2017-2030)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2017-2030)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product Type (2017-2030)
12.3.2. Market Revenue Forecast by End-user (2017-2030)
12.3.3. Market Revenue Forecast by Application (2017-2030)
12.3.4. Market Revenue Forecast by Sales Channel (2017-2030)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2017-2030)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2017-2030)
12.4. LATAM
12.4.1. Market Revenue Forecast by Product Type (2017-2030)
12.4.2. Market Revenue Forecast by End-user (2017-2030)
12.4.3. Market Revenue Forecast by Application (2017-2030)
12.4.4. Market Revenue Forecast by Sales Channel (2017-2030)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2017-2030)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2017-2030)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product Type (2017-2030)
12.5.2. Market Revenue Forecast by End-user (2017-2030)
12.5.3. Market Revenue Forecast by Application (2017-2030)
12.5.4. Market Revenue Forecast by Sales Channel (2017-2030)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2017-2030)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2017-2030)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2017-2030)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2017-2030)

Chapter 13. Company Profiles

13.1. Armstrong Medical Ltd
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio, Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin (2017-2020)
13.1.4. Recent Developments and Strategies
13.2. Becton Dickinson, and Company
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio, Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin (2017-2020)
13.2.4. Recent Developments and Strategies
13.3. Fisher & Paykel Healthcare Limited
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio, Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin (2017-2020)
13.3.4. Recent Developments and Strategies
13.4. Flexicare Medical Ltd
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio, Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin (2017-2020)
13.4.4. Recent Developments and Strategies
13.5. Hamilton Medical AG
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio, Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin (2017-2020)
13.5.4. Recent Developments and Strategies
13.6. ResMed, Inc.
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio, Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin (2017-2020)
13.6.4. Recent Developments and Strategies
13.7. Salter Labs Inc
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio, Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin (2017-2020)
13.7.4. Recent Developments and Strategies
13.8. Smiths Medical
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio, Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin (2017-2020)
13.8.4. Recent Developments and Strategies
13.9. Teijin Pharma Limited.
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio, Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin (2017-2020)
13.9.4. Recent Developments and Strategies
13.10. Teleflex Inc
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio, Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin (2017-2020)
13.10.4. Recent Developments and Strategies
13.11. TNI Medical AG
13.11.1. Company Overview, Business Information, Regional Presence
13.11.2. Product Portfolio, Analysis
13.11.2.1. Product Details, Specification, Application
13.11.3. Revenue, Price, and Gross Margin (2017-2020)
13.11.4. Recent Developments and Strategies
13.12. Vapotherm Inc.
13.12.1. Company Overview, Business Information, Regional Presence
13.12.2. Product Portfolio, Analysis
13.12.2.1. Product Details, Specification, Application
13.12.3. Revenue, Price, and Gross Margin (2017-2020)
13.12.4. Recent Developments and Strategies